← Eichor
Study identifier: NCT06385353 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

DVT Burden and the Risk of Post-thrombotic Syndrome

Condition: Postthrombotic Syndrome  ·  Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer

PhaseNA
Planned participants400
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Post-thrombotic syndrome (PTS) is the most common chronic complication of deep vein thrombosis (DVT), with major consequences for patient quality of life and cost of management. Identifying patients at high risk of developing PTS could be useful for its prevention and may lead to more appropriate therapeutic strategies to reduce its incidence and severity. Prognostic tools for predicting risk are very useful for choosing the optimum treatment and improving patient management and are a preliminary step before developing predictive models useful for determining sensitivity to treatment. At present, although several prognostic markers and models have been proposed, it is still difficult to predict who will develop a PTS or a moderate to severe PTS. The development of PTS is multifactorial and depends largely on the extent and severity of venous obstruction which supports the theory of thrombosis burden (DVT-Burden) as a potential prognostic marker for PTS. It therefore seems important to study the association between thrombosis burden and the occurrence of PTS. The Venous Volumetric Index or VVI (Ouriel 1999) will be used for quantifying DVT-Burden. The VVI was constructed by calculating the volume from the diameter and length of 14 venous segments from the calf veins to the inferior vena cava. The VVI has been validated for its ability to discriminate between symptomatic and asymptomatic DVT and has shown superior performance to other methods for quantifying DVT. This study …

This description comes directly from the study's public registry record.

Talk to the study team

Magali CESANA  ·  0483772060  ·  magali.cesana@ch-toulon.fr

Always discuss trial participation with your own doctor first.

Locations (27)

CH de VichyVichy, Allier, FranceRecruiting
Centre Hospitalier de CarcassonneCarcassonne, Aude, FranceRecruiting
Hôpital d'AubagneAubagne, Bouches-du-Rhône, FranceNot Yet Recruiting
Hôpital Saint JosephMarseille, Bouches-du-Rhône, FranceRecruiting
Hôpital La Timone, AP-HMMarseille, Bouches-du-Rhône, FranceRecruiting
Cabinet libéralMartigues, Bouches-du-Rhône, FranceTerminated
Cabinet libéralAjaccio, Corse-du-sud, FranceRecruiting
Cabinet libéralAjaccio, Corse-du-sud, FranceRecruiting
CHU de DijonDijon, Côte d'Or, FranceRecruiting
CHU de BesançonBesançon, Doubs, FranceRecruiting
Centre Hospitalier Universitaire de BrestBrest, Finistère, FranceRecruiting
Clinique Rive GaucheToulouse, Haut-Garonne, FranceRecruiting

+ 15 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06385353